Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection Figure 1: Treatment success rate with a single dose of neffy administered by a ...

An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...

NEW NASAL SPRAY, NOW APPROVED TO SAVE LIVES AFTER A SEVERE ALLERGIC REACTION. HERE TO TELL US MORE IS DOCTOR ALI RAJA, DEPUTY CHAIR OF THE DEPARTMENT OF EMERGENCY MEDICINE AT MASS GENERAL. DOCTOR RAJA ...

ANAHEIM, California — Paramedics who respond to emergency calls for patients with signs and symptoms of acute allergic reaction and anaphylaxis are failing to give life-saving epinephrine, according ...

Doctors prescribe EpiPen (epinephrine injection) to treat anaphylaxis from any cause, including food and medication allergies. Use EpiPen as soon as symptoms start or just after exposure to a known ...

I love a peanut butter and tuna sandwich. But when I was a kid, my school outlawed peanuts. My classmate was super allergic to them. So, we had a rule to keep our friend safe. I packed plain tuna fish ...

The nasal spray Neffy is the first non-injectable epinephrine to treat the life-threatening allergic response ARS Pharmaceuticals, Inc. The first-ever needle-free alternative to the EpiPen and similar ...

TORONTO, April 15, 2026 /CNW/ - ALK-Abello Pharmaceuticals Inc. Canada (ALK Canada) today announced that Health Canada has approved neffy ® 2 mg for the emergency treatment of allergic reactions ...

SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...